Literature DB >> 3497045

Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.

W L Tamminen, D Wraith, B H Barber.   

Abstract

An attempt has been made to generate monoclonal antibodies which recognize the same target structures on influenza-infected cells as those seen by cytotoxic T lymphocyte (CTL) receptors. Such antibodies, if they mimicked the T cell receptor specificity, would be expected to be both virus specific and restricted in their binding by the major histocompatibility complex (MHC) antigens. Approximately 200 hybridomas from C57BL/6 (H-2b) mice primed and boosted with influenza virus (X-31)-infected EL4 (a C57BL/6 T cell lymphoma) were screened for reactivity on infected and uninfected cells of different MHC haplotypes. Of the 10 hybridoma antibodies which were identified as being reactive with X-31-infected EL4, but not uninfected EL4, all reacted equally well with X-31-infected cells of H-2b, H-2d and H-2k haplotypes, indicating a lack of MHC restriction in their recognition of the infected cells. Unexpectedly, 7 of the 10 monoclonal antibodies were found to react specifically with the purified influenza virus nucleoprotein (NP), a predominant viral antigen in CTL recognition of infected cells. Fluorescence-activated flow cytometry confirmed that these antibodies were able to recognize NP serological determinants on the surface of viable, infected cells, but the anti-NP antibodies were unable to block the lytic activity of an NP-specific CTL clone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497045     DOI: 10.1002/eji.1830170716

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  An influenza haemagglutinin-specific IgG enhances class I MHC-restricted CTL killing in vitro.

Authors:  L McLain; N J Dimmock
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

2.  A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

Authors:  P S Andersen; A Stryhn; B E Hansen; L Fugger; J Engberg; S Buus
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

3.  Immunization with syngeneic Sendai virus-infected cells induce no MHC-restricted antibodies but antibodies specific for H-2 class I determinants.

Authors:  F Kievits; W J Boerenkamp; P Ivanyi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

Authors:  P Chames; S E Hufton; P G Coulie; B Uchanska-Ziegler; H R Hoogenboom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides.

Authors:  D S Burt; K H Mills; J J Skehel; D B Thomas
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

Review 6.  Opportunities and Challenges for Antibodies against Intracellular Antigens.

Authors:  Xiaofeng Yang; Shenxia Xie; Xiaomei Yang; Juan C Cueva; Xiaoqiong Hou; Zhuoran Tang; Hua Yao; Fengzhen Mo; Shihua Yin; Aiqun Liu; Xiaoling Lu
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

7.  T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment.

Authors:  Keith R Miller; Akiko Koide; Brenda Leung; Jonathan Fitzsimmons; Bryan Yoder; Hong Yuan; Michael Jay; Sachdev S Sidhu; Shohei Koide; Edward J Collins
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

8.  Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies.

Authors:  Adrian Chong Nyi Sim; Chien Tei Too; Min Zin Oo; Junyun Lai; Michelle Yating Eio; Zhenying Song; Nalini Srinivasan; Diane Ai Lin Tan; Shyue Wei Pang; Shu Uin Gan; Kok Onn Lee; Thomas Kwok Seng Loh; Jianzhu Chen; Soh Ha Chan; Paul Anthony MacAry
Journal:  Sci Rep       Date:  2013-11-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.